Skip to content

Combination of ERCP plus EUS-guided hepaticogastrostomy versus PTBD for biliary drainage in malignant hilar biliary obstruction: a prospective controlled trial

Combination of ERCP plus EUS-guided hepaticogastrostomy versus PTBD for biliary drainage in malignant hilar biliary obstruction: a prospective controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
TCTR
Registry ID
TCTR20180711004
Enrollment
Unknown
Registered
2018-07-11
Start date
2016-03-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Hilar Obstruction secondary to Cholangiocarcinoma Malignant hilar biliary obstruction&#44

Interventions

This group of patient consisted of patients with malignant hilar biliary obstruction who underwent combination or ERCP and EUS&#45
guided biliary drainage (CERES) for drainage of malignant biliary obstruction.
Supportive Care
Combination of ERCP and EUS&#45
BD (CERES)

Sponsors

King Chulalongkorn Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: a. Patients aged 18-85 b. Jaundiced patients with bile duct obstruction due to cholangiocarcinoma c. Clinical symptoms and findings that suggest that cholangiocarcinoma is the cause of obstruction d. Results of evaluation showing that they were not cured by surgery (unresectable tumors) e. Patients consented to endoscopic drainage

Exclusion criteria

Exclusion criteria: a. Pregnant patients b. Patients with contraindication to endoscopy

Design outcomes

Primary

MeasureTime frame
Rate of recurrent biliary obstruction of the CERES procedure 3 months Number of subjects with recurrent biliary obstruction at month 3

Secondary

MeasureTime frame
Time to biliary reinterventions about 3-12 months Duration from successful CERES procedure to biliary reintervention procedure

Countries

Thailand

Contacts

Public ContactPradermchai Kongkam

King Chulalongkorn Memorial Hospital

pkongkam@gmail.com0805575111

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026